Self-Assembling Peptides with Insulin-Like Growth Factor Mimicry

Document Type

Article

Publication Date

1-10-2024

Abstract

Growth factor (GF) mimicry involves recapitulating the signaling of larger molecules or cells. Although GF mimicry holds considerable promise in tissue engineering and drug design applications, difficulties in targeting the signaling molecule to the site of delivery and dissociation of mimicking peptides from their target receptors continue to limit its clinical application. To address these challenges, we utilized a self-assembling peptide (SAP) platform to generate synthetic insulin-like growth factor (IGF)-signaling, self-assembling GFs. Our peptide hydrogels are biocompatible and bind target IGF receptors in a dose-dependent fashion, activate proangiogenic signaling, and facilitate formation of angiogenic microtubules in vitro. Furthermore, infiltrated hydrogels are stable for weeks to months. We conclude that the enhanced targeting and long-term stability of our SAP/GF mimicry implants may improve the efficacy and safety of future GF mimic therapeutics.

Identifier

85181803030 (Scopus)

Publication Title

ACS Applied Materials and Interfaces

External Full Text Location

https://doi.org/10.1021/acsami.3c15660

e-ISSN

19448252

ISSN

19448244

PubMed ID

38145951

First Page

364

Last Page

375

Issue

1

Volume

16

Grant

R15 EY029504

Fund Ref

National Institutes of Health

This document is currently not available here.

Share

COinS